TRIM25: A central factor in breast cancer

doi:10.5306/wjco.v12.i8.646

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10357)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

560

WORD

185

HTML

5401

Figures (1-3)

758

Sum=6904

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

379

Download

1059

Sum=1438

Publishing Process of This Article

Item

Count

Browse

573

Download

1444

Sum=2017

Aug 24, 2021 (publication date) through Mar 2, 2026

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Clin Oncol. Aug 24, 2021; 12(8): 646-655
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.646

TRIM25: A central factor in breast cancer

Angeles C Tecalco-Cruz, María Jazmin Abraham-Juárez, Helena Solleiro-Villavicencio, Josué Orlando Ramírez-Jarquín

Angeles C Tecalco-Cruz, Helena Solleiro-Villavicencio, Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México (UACM), Mexico 03100, Mexico

María Jazmin Abraham-Juárez, Laboratorio Nacional de Genómica para la Biodiversidad (LANGEBIO), Unidad de Genómica Avanzada, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Irapuato 36821, Mexico

Josué Orlando Ramírez-Jarquín, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico 04510, Mexico

Author contributions: Tecalco-Cruz AC planned the study, participated in the research, organization of this article, and wrote the manuscript; Abraham–Juárez MJ, Solleiro–Villavicencio H and Ramírez-Jarquín JO participated in the research, wrote some part of the manuscript, and prepared some figures of this article.

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Corresponding author: Angeles C Tecalco-Cruz, PhD, Full Professor, Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México (UACM), Colonia Del valle, San Lorenzo 290, Mexico 03100, Mexico. angeles.tecalco@uacm.edu.mx

Received: February 1, 2021
Peer-review started: February 1, 2021
First decision: March 31, 2021
Revised: April 2, 2021
Accepted: July 27, 2021
Article in press: July 27, 2021
Published online: August 24, 2021
Processing time: 202 Days and 9.1 Hours

Core Tip

Core Tip: TRIM25 is an E3-ligase enzyme for the ubiquitination and ISGylation system. TRIM25 expression is deregulated in breast cancer. The activity of TRIM25 is associated with changes in the proteome of mammary tumors. The molecular mechanisms of modulation and action of TRIM25 are implicated in breast cancer progression.